METHOCEL™ Premium CR Cellulose Ethers

First choice for the formulation of hydrophilic matrix systems, providing a robust mechanism for the extended/controlled release of drugs from oral solid dosage forms. With a choice of viscosity grades METHOCEL™ premium cellulose ethers provide a simple solution to meet a range of drug solubility needs. Tablets are easily manufactured with existing, conventional equipment and processing methods.

Matrix Tablet Formulations

ApplicationBenefits Typically Used METHOCEL™ Cellulose Ethers
Low Solubility Drugs Fast polymer hydration to form gel layer; non-ionic E50LV, K100LV, K100LV CR
Med to High Solubility Drug Fast polymer hydration to form gel layer; non-ionic K4M, K15M, K100M, E4M, E10M, K4MCR, K15MCR, K100MCR, E4MCR, E10MCR

Colorcon, through the Controlled Release Alliance, has exclusive, global sales and distribution rights for METHOCEL™ products from IFF for use in controlled release applications.


METHOCEL™ is a trademark of International Flavors and Fragrances Inc. or its affiliates. 

© 2021 IFF.  All rights reserved 

Platform Solutions

Colorcon can help to reduce your project time by providing the right solution through excipient selection and process guidance.


Lower total cost and reduce time to market

Dissolution Design

Life cycle management through modified delivery profiles and product line extensions

Patient Adherence

Reduce medication errors and improve patient adherence


Stable and consistent product performance

Product Authentication

Track and trace